Among the rarest of diagnoses, male breast cancer has long existed at the margins of medical attention — too uncommon to anchor public awareness, yet consequential enough to claim lives. A quarter-century of Spanish data now offers a quieter kind of progress report: men are not developing the disease more often, but they are surviving it at steadily improving rates, a testament to the slow, unglamorous work of better clinical care. The study also illuminates how profoundly this disease differs from its female counterpart — in anatomy, in hormonal dependence, in genetic signature — reminding us